- Neratinib in the context of an early breast cancer anti-HER2 therapy2020 | First Faculty of Medicine
- Lipid-modifying therapies of tomorrow - what will they be like?2012 | First Faculty of Medicine
- Gastrointestinal tract toxicity of systemic oncology therapy2016 | Faculty of Medicine in Pilsen
- Microscopic colitis2013 | First Faculty of Medicine, Third Faculty of Medicine
- Nintedanib in treating interstitial lung disease associated with systemic scleroderma2021 | First Faculty of Medicine, Second Faculty of Medicine
- Management of diarrhea as an undesirable effect of treatment with afatinib - case report2017 | Faculty of Medicine in Pilsen
- Gastrointestinal toxicity of systemic oncology immunotherapy2022 | First Faculty of Medicine, Central Library of Charles University